Status:
COMPLETED
Growth Hormone Evaluation in the Elderly People
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Aging
Eligibility:
All Genders
65-95 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the growth hormone (GH) and adrenocorticotrophic hormone (ACTH) secretion in elderly without hypothalamic-pituitary disease using the glucagon stimulation test (us...
Detailed Description
subjects over 65 years old were recruited from the geriatric ambulatory unit of our hospital to voluntarily participate in a research study concerning the GH and ACTH axis in the elderly, which includ...
Eligibility Criteria
Inclusion
- elderly people above 65 years old with comorbidities peculiar to their age (such as hypertension, diabetes, dyslipidemia, parkinson disease) or without comorbidities
Exclusion
- pituitary disease, severe acute disease, terminal renal chronic disease, active malignant cancer, the presence of any other disease that could interfere with the somatotrophic axis evaluation, and the contraindications for glucagon administration (pheochromocytoma, insulinoma and malnourishment).
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02240043
Start Date
September 1 2011
End Date
August 1 2013
Last Update
September 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.